These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33997178)

  • 1. VPS33B suppresses lung adenocarcinoma metastasis and chemoresistance to cisplatin.
    Liu Z; Liu J; Li Y; Wang H; Liang Z; Deng X; Fu Q; Fang W; Xu P
    Genes Dis; 2021 May; 8(3):307-319. PubMed ID: 33997178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VPS33B negatively modulated by nicotine functions as a tumor suppressor in colorectal cancer.
    Chen Y; Liu Z; Wang H; Tang Z; Liu Y; Liang Z; Deng X; Zhao M; Fu Q; Li L; Cai H; Xie W; Fang W
    Int J Cancer; 2020 Jan; 146(2):496-509. PubMed ID: 31125123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VPS33B interacts with NESG1 to suppress cell growth and cisplatin chemoresistance in ovarian cancer.
    Ning Y; Zeng Z; Deng Y; Feng W; Huang L; Liu H; Lin J; Zhang C; Fan Y; Liu L
    Cancer Sci; 2021 May; 112(5):1785-1797. PubMed ID: 33788346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VPS33B interacts with NESG1 to modulate EGFR/PI3K/AKT/c-Myc/P53/miR-133a-3p signaling and induce 5-fluorouracil sensitivity in nasopharyngeal carcinoma.
    Liang Z; Liu Z; Cheng C; Wang H; Deng X; Liu J; Liu C; Li Y; Fang W
    Cell Death Dis; 2019 Apr; 10(4):305. PubMed ID: 30944308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VPS33B modulates c-Myc/p53/miR-192-3p to target CCNB1 suppressing the growth of non-small cell lung cancer.
    Liu J; Wen Y; Liu Z; Liu S; Xu P; Xu Y; Deng S; Hu S; Luo R; Jiang J; Yu G
    Mol Ther Nucleic Acids; 2021 Mar; 23():324-335. PubMed ID: 33425490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miRomics and Proteomics Reveal a miR-296-3p/PRKCA/FAK/Ras/c-Myc Feedback Loop Modulated by HDGF/DDX5/β-catenin Complex in Lung Adenocarcinoma.
    Fu Q; Song X; Liu Z; Deng X; Luo R; Ge C; Li R; Li Z; Zhao M; Chen Y; Lin X; Zhang Q; Fang W
    Clin Cancer Res; 2017 Oct; 23(20):6336-6350. PubMed ID: 28751441
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-296-3p Negatively Regulated by Nicotine Stimulates Cytoplasmic Translocation of c-Myc via MK2 to Suppress Chemotherapy Resistance.
    Deng X; Liu Z; Liu X; Fu Q; Deng T; Lu J; Liu Y; Liang Z; Jiang Q; Cheng C; Fang W
    Mol Ther; 2018 Apr; 26(4):1066-1081. PubMed ID: 29525743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma.
    Liu JH; Yang HL; Deng ST; Hu Z; Chen WF; Yan WW; Hou RT; Li YH; Xian RT; Xie YY; Su Y; Wu LY; Xu P; Zhu ZB; Liu X; Deng YL; Wang YB; Liu Z; Fang WY
    Acta Pharmacol Sin; 2022 Oct; 43(10):2687-2695. PubMed ID: 35296779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CNTN-1 Enhances Chemoresistance in Human Lung Adenocarcinoma Through Induction of Epithelial-Mesenchymal Transition by Targeting the PI3K/Akt Pathway.
    Zhang R; Sun S; Ji F; Liu C; Lin H; Xie L; Yang H; Tang W; Zhou Y; Xu J; Li P
    Cell Physiol Biochem; 2017; 43(2):465-480. PubMed ID: 28934754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
    Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
    Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EIF3H interacts with PDCD4 enhancing lung adenocarcinoma cell metastasis.
    Hu Y; Wei X; Lv Y; Xie X; Yang L; He J; Tao X; Ma Y; Su Y; Wu L; Fang W; Liu Z
    Am J Cancer Res; 2020; 10(1):179-195. PubMed ID: 32064160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human RECQL5 promotes metastasis and resistance to cisplatin in non-small cell lung cancer.
    Xia HW; Zhang ZQ; Yuan J; Niu QL
    Life Sci; 2021 Jan; 265():118768. PubMed ID: 33217443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of RCC2 Enhances Cell Motility and Promotes Tumor Metastasis in Lung Adenocarcinoma by Inducing Epithelial-Mesenchymal Transition.
    Pang B; Wu N; Guan R; Pang L; Li X; Li S; Tang L; Guo Y; Chen J; Sun D; Sun H; Dai J; Bai J; Ji G; Liu P; Liu A; Wang Q; Xiao S; Fu S; Jin Y
    Clin Cancer Res; 2017 Sep; 23(18):5598-5610. PubMed ID: 28606921
    [No Abstract]   [Full Text] [Related]  

  • 15. MicroRNA-451 induces epithelial-mesenchymal transition in docetaxel-resistant lung adenocarcinoma cells by targeting proto-oncogene c-Myc.
    Chen D; Huang J; Zhang K; Pan B; Chen J; De W; Wang R; Chen L
    Eur J Cancer; 2014 Nov; 50(17):3050-67. PubMed ID: 25310895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shikonin Inhibited Migration and Invasion of Human Lung Cancer Cells via Suppression of c-Met-Mediated Epithelial-to-Mesenchymal Transition.
    Hsieh YS; Liao CH; Chen WS; Pai JT; Weng MS
    J Cell Biochem; 2017 Dec; 118(12):4639-4651. PubMed ID: 28485480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting 14-3-3ζ Overcomes Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Lung Adenocarcinoma via BMP2/Smad/ID1 Signaling.
    Cui J; Song Y; Han X; Hu J; Chen Y; Chen X; Xu X; Xing Y; Lu H; Cai L
    Front Oncol; 2020; 10():542007. PubMed ID: 33123465
    [No Abstract]   [Full Text] [Related]  

  • 18. Alkaline phosphatase downregulation promotes lung adenocarcinoma metastasis via the c-Myc/RhoA axis.
    Lou Z; Lin W; Zhao H; Jiao X; Wang C; Zhao H; Liu L; Liu Y; Xie Q; Huang X; Huang H; Zhao L
    Cancer Cell Int; 2021 Apr; 21(1):217. PubMed ID: 33858415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of metastatic potential by inhibiting EGFR/Akt/p38/ERK signaling pathway and epithelial-mesenchymal transition after carbon ion exposure is potentiated by PARP-1 inhibition in non-small-cell lung cancer.
    Chowdhury P; Dey P; Ghosh S; Sarma A; Ghosh U
    BMC Cancer; 2019 Aug; 19(1):829. PubMed ID: 31438892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-206 regulates cisplatin resistance and EMT in human lung adenocarcinoma cells partly by targeting MET.
    Chen QY; Jiao DM; Wang J; Hu H; Tang X; Chen J; Mou H; Lu W
    Oncotarget; 2016 Apr; 7(17):24510-26. PubMed ID: 27014910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.